• HCA Healthcare, Inc. (NYSE:HCA) reported an EPS of $6.22, exceeding both the estimated $6.13 and the Zacks Consensus Estimate of $5.97.
• The company's revenue for the quarter was $18.29 billion, slightly above the estimated $18.23 billion.
• HCA's financial metrics reveal a price-to-earnings (P/E) ratio of 13.96 and an earnings yield of approximately 7.17%.

HCA Healthcare, Inc. (NYSE:HCA) is a prominent player in the healthcare sector, providing a wide range of medical services across the United States. The company operates hospitals and outpatient facilities, offering comprehensive healthcare services. HCA competes with other major healthcare providers like Tenet Healthcare and Community Health Systems.

On January 24, 2025, HCA reported earnings per share (EPS) of $6.22, surpassing the estimated $6.13. This performance also exceeded the Zacks Consensus Estimate of $5.97 per share, showcasing HCA's ability to outperform market expectations. Compared to the previous year's same quarter EPS of $5.90, this indicates a positive growth trajectory for the company.

HCA's revenue for the quarter reached $18.29 billion, slightly above the estimated $18.23 billion. The company reported $18.3 billion in revenue for the fourth quarter of 2024, with net income attributable to HCA amounting to $1.4 billion, or $5.63 per diluted share. This figure includes an estimated unfavorable impact of $0.60 per diluted share due to Hurricanes Helene and M.

HCA's financial metrics provide insight into its market valuation. The company has a price-to-earnings (P/E) ratio of approximately 13.96, indicating how the market values its earnings. Its price-to-sales ratio is about 1.17, reflecting investor willingness to pay per dollar of sales. The enterprise value to sales ratio is around 1.78, showing the company's total valuation relative to its sales.

HCA's financial structure is unique, with a negative debt-to-equity ratio of -20.57, which may suggest specific accounting treatments. The company maintains a current ratio of approximately 1.12, indicating its ability to cover short-term liabilities with short-term assets. HCA's earnings yield is about 7.17%, providing a measure of return on investment for shareholders.